scispace - formally typeset
Journal ArticleDOI

Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.

Reads0
Chats0
TLDR
A large group of patients with differentiated thyroid carcinoma who had serum thyroid peroxidase, thyroglobulin, or TSH-receptor antibodies due to coexistent thyroid autoimmune disease were studied, finding gradual disappearance of antibodies gradually disappeared in most patients.
Abstract
Le malattie autoimmuni della tiroide sono caratterizzate dalla presenza di anticorpi diretti contro la tireoperossidasi (TPO), la tireoglobulina (Tg) e il recettore per l’ormone tireotropo (TSH-R). Questo studio ha valutato se la rimozione completa degli antigeni tiroidei fosse in grado di indurre la scomparsa dei segni di autoimmunita tiroidea circolante. Lo studio e basato su una revisione retrospettiva delle cartelle cliniche di pazienti che erano stati seguiti e trattati secondo un protocollo standard. Sono stati studiati 182 pazienti affetti da tumore differenziato della tiroide i quali, per la coesistenza di una tiroidite cronica autoimmune, di un morbo di Basedow o di una tiroidite focale autoimmune, risultavano positivi per anticorpi anti-TPO (TPOAb), anti-Tg (TgAb) o anti-TSH-R (TRAb). Dei 182 soggetti, 151 erano di sesso femminile e 31 di sesso maschile; l’eta media era di 39,7±13,7 anni, con un range da 6 a 81 anni. Tutti i pazienti sono stati sottoposti a tiroidectomia totale e a trattamento con iodio radioattivo allo scopo di ablare il tessuto tiroideo residuo o metastatico. Il follow-up e stato effettuato mediante scintigrafie corporee totali con radioiodio e dosaggio della Tg circolante. La media del follow-up era di 10,1±4,1 anni, con un range di 4–20 anni. A seguito del trattamento con tiroidectomia totale e iodio radioattivo, si e verificata la scomparsa dei TgAb, TPOAb e TRAb. La mediana di scomparsa e stata di 6,3 anni per iTPOAb e di 3,0 anni per i TgAb. La scomparsa del tessuto tiroideo e quella degli anticorpi antitiroide erano correlate in modo statisticamente significativo. La persistenza di TPOAb e TgAb non veniva influenzata dal sesso, dall’eta e dalla concomitanza della tiroidite autoimmune o del morbo di Basedow.

read more

Citations
More filters
Journal ArticleDOI

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

TL;DR: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Furio Pacini, Martin Schlumberger, Henning Dralle, Rossella Elisei, Johannes W A Smit, Wilmar Wiersinga and the European Thyroid Cancer Taskforce Section of Endocrinology and Metabolism are presented.
Journal ArticleDOI

Competence and competition : the challenge of becoming a long-lived plasma cell

TL;DR: Studies of the biology of plasma cells reveal a mechanism of intriguing simplicity and elegance that focuses memory provided by plasma cells on recently encountered pathogens while minimizing the 'fading' of memory for pathogens encountered in the distant past.
References
More filters
Journal ArticleDOI

Autoimmune thyroid disease: further developments in our understanding

TL;DR: The revolution in molecular techniques has allowed dissection of the autoimmune response in a way impossible to imagine 10 yr ago, but there have been no really major improvements in the understanding of the immunogenetics of thyroid autoimmunity, equivalent to those made in type 1 diabetes mellitus.
Journal ArticleDOI

The thyroid : a fundamental and clinical text

TL;DR: This book is an important reference text on the thyroid gland for workers in a wide variety of disciplines and will be disappointing to doctors currently setting up in vitro laboratory techniques for nuclear medicine.
Journal ArticleDOI

Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.

TL;DR: The RIA method used in this study provided more clinically appropriate serum Tg values in the group of TgAb-positive patients with metastatic DTC and may be an additional clinically useful tumor marker parameter for following T gAb- positive patients.
Journal ArticleDOI

Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation

TL;DR: This study was designed to investigate whether an elevated serum antithyroglobulin antibody (TgAb) reflects cancer recurrence in thyrogLobulin (TG)‐undetectable patients with differentiated thyroid carcinoma (DTC) after thyroid ablation.
Journal ArticleDOI

Surgical treatment of graves' disease: Subtotal or total thyroidectomy?†

TL;DR: Total thyroidectomy does not present more complications with respect to subtotal thyroidectomy, but it avoids the worsening of thyroid humoral autoimmunity and the relapse of hyperthyroidism, so it could represent the treatment of choice in Graves' disease.
Related Papers (5)